Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention J Marsh, P Alifragis Neural regeneration research 13 (4), 616-623, 2018 | 169 | 2018 |
Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons B Tanudjojo, SS Shaikh, A Fenyi, L Bousset, D Agarwal, J Marsh, C Zois, ... Nature communications 12 (1), 3817, 2021 | 73 | 2021 |
Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine Z Fan, C Jiang, Y Wang, K Wang, J Marsh, D Zhang, X Chen, L Nie Nanoscale horizons 7 (7), 682-714, 2022 | 59 | 2022 |
Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid J Marsh, SH Bagol, RSB Williams, G Dickson, P Alifragis Neurobiology of Disease 106, 63-75, 2017 | 43 | 2017 |
Monitoring α-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation D Zenko, J Marsh, AR Castle, R Lewin, R Fischer, GK Tofaris Science Advances 9 (24), eadd8910, 2023 | 14 | 2023 |
Investigation into the mechanisms of intraneuronal amyloid-ß and apolipoprotein E driven pathology in Alzheimer's disease JD Marsh Royal Holloway, University of London, 2019 | | 2019 |
阿尔茨海默病中的突触功能障碍: Aβ 在突触小泡动力学中作为治疗干预的新靶标的作用 J Marsh, P Alifragis 中国神经再生研究 (英文版) 13 (4), 616, 2018 | | 2018 |
TALEN-directed genome surgery of the DMD gene L Popplewell, J Marsh, H Kymaelaeinen, RJ Yanez-Munoz, G Dickson HUMAN GENE THERAPY 24 (5), A21-A21, 2013 | | 2013 |